The current study aims to identify global genetic variations and different bioinformatics (e.g., molecular function and biological processes) of genes in chromosome 4 among subtypes of lung cancer as potential candidates of biomarkers and evaluate prediction value OPN in ADC and SCC for the prognosis of patients. This evidence concerns the gene SPP1 and lung cancer.